Cargando…

Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older in the United States

The Centers for Disease Control and Prevention announced in January 2023 a potential connection between administration of the Pfizer novel coronavirus disease-2019 (COVID-19) bivalent vaccine booster and ischemic stroke (IS). A retrospective cohort study was conducted to compare the hazard of IS in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorenflo, Maria P., Davis, Pamela B., Kaelber, David C., Xu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667491/ https://www.ncbi.nlm.nih.gov/pubmed/37996515 http://dx.doi.org/10.1038/s41541-023-00777-w

Ejemplares similares

Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older: analysis of nation-wide patient electronic health records in the United States
por: Gorenflo, Maria P., et al.
Publicado: (2023)

COVID‐19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021
por: Wang, Lindsey, et al.
Publicado: (2022)

Suicidal ideation and suicide attempt following ketamine prescription in patients with treatment-resistant depression: a nation-wide cohort study
por: Pan, Yiheng, et al.
Publicado: (2023)

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses
por: Gao, Zhenxiang, et al.
Publicado: (2023)

Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2023)

A narrative review of tuberculosis in the United States among persons aged 65 years and older
por: Wu, Iris L., et al.
Publicado: (2022)

Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023
por: Liu, Bette, et al.
Publicado: (2023)

1797. Pneumococcal Vaccination in Veterans 65 years and older with Pneumococcus in the Veterans Health Administration (VHA) since November 2021
por: Schirmer, Patricia, et al.
Publicado: (2023)

Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration
por: Gao, Zhenxiang, et al.
Publicado: (2023)

Immunogenicity of Individual Vaccine Components in a Bivalent Nicotine Vaccine Differ According to Vaccine Formulation and Administration Conditions
por: Cornish, Katherine E., et al.
Publicado: (2013)

Trends in Acute Ischemic Stroke Hospitalizations in the United States
por: Ramirez, Lucas, et al.
Publicado: (2016)

Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older
por: Biyik, M. V., et al.
Publicado: (2020)

Invasive Haemophilus influenzae Disease in Adults ≥65 Years, United States, 2011
por: Blain, Amy, et al.
Publicado: (2014)

State-Specific Healthy Life Expectancy at Age 65 Years — United States, 2007–2009
por: Chang, Man-Huei, et al.
Publicado: (2013)

Temperature and Precipitation Associate With Ischemic Stroke Outcomes in the United States
por: Chu, Stacy Y., et al.
Publicado: (2018)

1941. Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults
por: Baber, James A, et al.
Publicado: (2023)

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

The Associations Between Older Driver Licensure Laws with Travel and Passenger Behaviors Among Adults Aged 65 Years or Older (United States, 2003–2017)
por: Shen, Sijun, et al.
Publicado: (2021)

Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
por: Clua-Espuny, Jose-Luis, et al.
Publicado: (2020)

mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
por: Tseng, Hung Fu, et al.
Publicado: (2023)

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine
por: Ramani, Sasirekha, et al.
Publicado: (2017)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
por: Surie, Diya, et al.
Publicado: (2022)

Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17
por: Pebody, Richard G, et al.
Publicado: (2018)

Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States
por: de Havenon, Adam, et al.
Publicado: (2021)

Time Trend and Association of Early-Onset Colorectal Cancer with Diverticular Disease in the United States: 2010–2021
por: Wang, Lindsey, et al.
Publicado: (2022)

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
por: Moulia, Danielle L., et al.
Publicado: (2023)

Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022
por: Sinclair, Alyssa H., et al.
Publicado: (2023)

Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older
por: McDonald, Margaret, et al.
Publicado: (2009)

Life Beyond 65: Changing Spatial Patterns of Survival at Older Ages in the United States, 2000–2016
por: Vierboom, Yana C, et al.
Publicado: (2020)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster
por: Jabagi, Marie-Joelle, et al.
Publicado: (2023)

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
por: Shiragami, Makoto, et al.
Publicado: (2019)

Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older
por: Wong, Hui-Lee, et al.
Publicado: (2023)

Association of Frailty and Suicide in Adults 65 Years and Older
por: Kuffel, Randall, et al.
Publicado: (2021)

Deaths from Falls Among Persons Aged ≥65 Years — United States, 2007–2016
por: Burns, Elizabeth, et al.
Publicado: (2018)

2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023
por: DeCuir, Jennifer, et al.
Publicado: (2023)

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

Rotavirus Vaccine Administration Errors — United States, 2006–2013
por: Hibbs, Beth F., et al.
Publicado: (2014)

EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom
por: Kohli, M., et al.
Publicado: (2023)

Incidence and mortality rates of acute ischemic stroke in hospitalized patients in the United States
por: Ramphul, Kamleshun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8fm84pmic0k7qa1oqvrci8gq5o